 | Reneo Pharmaceuticals, Inc. | |||
| NGM : RPHM || Location: United States | ||||
$1.74-0.02 (-1.14%) |
0.08 M | 1.7 - 1.75 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.917 M |
| March 15, 2024 | 2.824 M |
| Feb. 29, 2024 | 2.587 M |
| Feb. 15, 2024 | 2.000 M |
| Jan. 31, 2024 | 1.632 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.59 | -0.71 | -20.46% |
| 09/30/2023 | -0.58 | -0.57 | 2.21% |
| 06/30/2023 | -0.53 | -0.65 | -23.34% |
| 03/31/2023 | -0.62 | -0.60 | 2.61% |
| 12/31/2022 | -0.61 | -0.56 | 8.62% |
RPHM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 33.421M | Shares Float | 14.755M |
| Short Float | 2.917M | Market Cap | 58.82M |
| Institution ownership | 82.14% | Insider ownership | 3.004% |
| Earnings Date | 05/08/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.52 | Forward EPS | -0.55 |